Trial
NCT05545072
Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Sanofi
Condition
Allergic Fungal Rhinosinusitis
Intervention
Dupilumab
Why stopped
The study was terminated due to funding ending.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-08